Dynamics of human protein kinase Aurora A linked to drug selectivity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamics of human protein kinase Aurora A linked to drug selectivity
Authors
Keywords
-
Journal
eLife
Volume 7, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2018-06-14
DOI
10.7554/elife.36656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation
- (2018) Emily F Ruff et al. eLife
- A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
- (2017) Ankit C. Borisa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Switching Aurora-A kinase on and off at an allosteric site
- (2017) Richard Bayliss et al. FEBS Journal
- Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance
- (2017) Nicole Willemsen-Seegers et al. JOURNAL OF MOLECULAR BIOLOGY
- A water-mediated allosteric network governs activation of Aurora kinase A
- (2017) Soreen Cyphers et al. Nature Chemical Biology
- Identification of small molecule inhibitors of the Aurora-A/TPX2 complex
- (2017) Italia Anna Asteriti et al. Oncotarget
- CheckMyMetal: a macromolecular metal-binding validation tool
- (2017) Heping Zheng et al. Acta Crystallographica Section D-Structural Biology
- Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening
- (2016) Falco Kilchmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain
- (2016) Selena G. Burgess et al. Open Biology
- Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2
- (2016) Matej Janeček et al. Scientific Reports
- 7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent
- (2015) Vassilios Bavetsias et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors
- (2015) Sailu Sarvagalla et al. CURRENT CANCER DRUG TARGETS
- Computational Study of the “DFG-Flip” Conformational Transition in c-Abl and c-Src Tyrosine Kinases
- (2015) Yilin Meng et al. JOURNAL OF PHYSICAL CHEMISTRY B
- The drug–target residence time model: a 10-year retrospective
- (2015) Robert A. Copeland NATURE REVIEWS DRUG DISCOVERY
- Using ancient protein kinases to unravel a modern cancer drug's mechanism
- (2015) C. Wilson et al. SCIENCE
- Dynamics-Driven Allostery in Protein Kinases
- (2015) Alexandr P. Kornev et al. TRENDS IN BIOCHEMICAL SCIENCES
- Aurora Kinase Inhibitors: Current Status and Outlook
- (2015) Vassilios Bavetsias et al. Frontiers in Oncology
- Drugging MYCN through an Allosteric Transition in Aurora Kinase A
- (2014) William Clay Gustafson et al. CANCER CELL
- Identification of a Major Determinant for Serine-Threonine Kinase Phosphoacceptor Specificity
- (2014) Catherine Chen et al. MOLECULAR CELL
- Energetic dissection of Gleevec's selectivity toward human tyrosine kinases
- (2014) Roman V Agafonov et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Specificity Rendering ‘Hot-Spots’ for Aurora Kinase Inhibitor Design: The Role of Non-Covalent Interactions and Conformational Transitions
- (2014) Preethi Badrinarayan et al. PLoS One
- Activation pathway of Src kinase reveals intermediate states as targets for drug design
- (2014) Diwakar Shukla et al. Nature Communications
- Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2
- (2014) Adelajda Zorba et al. eLife
- ACHESYM: an algorithm and server for standardized placement of macromolecular models in the unit cell
- (2014) Marcin Kowiel et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Antimitotic drugs in cancer chemotherapy: Promises and pitfalls
- (2013) Isabel Marzo et al. BIOCHEMICAL PHARMACOLOGY
- Ins and Outs of Kinase DFG Motifs
- (2013) Daniel K. Treiber et al. CHEMISTRY & BIOLOGY
- Nmrglue: an open source Python package for the analysis of multidimensional NMR data
- (2013) Jonathan J. Helmus et al. JOURNAL OF BIOMOLECULAR NMR
- A Computational Model for Overcoming Drug Resistance Using Selective Dual-Inhibitors for Aurora Kinase A and Its T217D Variant
- (2013) Khaled H. Barakat et al. MOLECULAR PHARMACEUTICS
- Improved low-resolution crystallographic refinement with Phenix and Rosetta
- (2013) Frank DiMaio et al. NATURE METHODS
- Structure-kinetic relationship study of CDK8/CycC specific compounds
- (2013) E. V. Schneider et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Mechanism by Which Small Molecule Inhibitors Induce the DFG Flip in Aurora A
- (2012) Mathew P. Martin et al. ACS Chemical Biology
- Towards automated crystallographic structure refinement withphenix.refine
- (2012) Pavel V. Afonine et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Aurora A kinase (AURKA) in normal and pathological cell division
- (2012) Anna S. Nikonova et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Simple and inexpensive incorporation of 19F-Tryptophan for protein NMR spectroscopy
- (2012) Peter B. Crowley et al. CHEMICAL COMMUNICATIONS
- Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits Growth of Liver Metastases from Gastroenteropancreatic Neuroendocrine Tumors in an Orthotopic Xenograft Model
- (2012) K. Fraedrich et al. CLINICAL CANCER RESEARCH
- Aurora kinase inhibitors: Progress towards the clinic
- (2012) Madhu Kollareddy et al. INVESTIGATIONAL NEW DRUGS
- The Different Flexibility of c-Src and c-Abl Kinases Regulates the Accessibility of a Druggable Inactive Conformation
- (2012) Silvia Lovera et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Evolution of the eukaryotic protein kinases as dynamic molecular switches
- (2012) S. S. Taylor et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM
- (2011) T. Geoff G. Battye et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Backbone assignment of the tyrosine kinase Src catalytic domain in complex with imatinib
- (2011) Ramón Campos-Olivas et al. Biomolecular NMR Assignments
- Current applications of 19F NMR to studies of protein structure and dynamics
- (2011) Julianne L. Kitevski-LeBlanc et al. PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Aurora kinase inhibitors as anti-cancer therapy
- (2010) Warren Lok et al. ANTI-CANCER DRUGS
- Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design
- (2010) Charlotte A. Dodson et al. BIOCHEMICAL JOURNAL
- Aurora kinase inhibitors as anticancer molecules
- (2010) Hiroshi Katayama et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
- (2010) John Wojcik et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Defining the conserved internal architecture of a protein kinase
- (2009) Alexandr P. Kornev et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
- (2009) M. A. Seeliger et al. CANCER RESEARCH
- Aurora A, centrosome structure, and the centrosome cycle
- (2009) Kara B. Lukasiewicz et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- xia2: an expert system for macromolecular crystallography data reduction
- (2009) G. Winter JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors
- (2009) Neeltje Steeghs et al. JOURNAL OF CLINICAL ONCOLOGY
- Global Kinetic Explorer: A new computer program for dynamic simulation and fitting of kinetic data
- (2008) Kenneth A. Johnson et al. ANALYTICAL BIOCHEMISTRY
- Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation
- (2008) Arvin C. Dar et al. CHEMISTRY & BIOLOGY
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Solution Conformations and Dynamics of ABL Kinase-Inhibitor Complexes Determined by NMR Substantiate the Different Binding Modes of Imatinib/Nilotinib and Dasatinib
- (2008) Navratna Vajpai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity†
- (2008) Steven Howard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Modulation of kinase-inhibitor interactions by auxiliary protein binding: Crystallography studies on Aurora A interactions with VX-680 and with TPX2
- (2008) Baoguang Zhao et al. PROTEIN SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now